Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

The malignant pilomatricoma showed strong epithelial keratin expression, suggesting it may not calcify.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

A benign skin tumor was removed from a man's leg, and it didn't come back after 9 months.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

The hamster polyomavirus middle T antigen is linked to tumors in hamsters and associates with a specific tyrosine kinase.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Alopecia areata helps study T cell-driven autoimmune diseases.

Imatinib can cause hair loss due to lichen planopilaris.

A man's neck lump was a trichilemmal cyst, not cancer, and should be fully removed due to rare risk of becoming malignant.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Erlotinib may cause scarring hair loss.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

LRIG1 is linked to better survival in Merkel cell carcinoma.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Trichohyalin in hair can trigger immune attacks in alopecia areata.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

A stable cell line for hair research was created without causing tumors.

Activating TERT in mice skin boosts hair growth by waking up hair follicle stem cells.

Different tumor cells in one basal cell carcinoma can cause mixed treatment responses, suggesting personalized treatment is needed.